These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20209618)

  • 21. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy related acute non-lymphocytic leukemia: report of 4 cases.
    Atichartakarn V; Punyammalee B; Nitiyanant P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):421-30. PubMed ID: 4095607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
    Curtis RE; Hankey BF; Myers MH; Young JL
    J Natl Cancer Inst; 1984 Mar; 72(3):531-44. PubMed ID: 6583439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
    Shuryak I; Sachs RK; Hlatky L; Little MP; Hahnfeldt P; Brenner DJ
    J Natl Cancer Inst; 2006 Dec; 98(24):1794-806. PubMed ID: 17179481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Teta MJ; Lau E; Sceurman BK; Wagner ME
    Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second neoplasms following radiotherapy or chemotherapy for cancer.
    Penn I
    Am J Clin Oncol; 1982 Feb; 5(1):83-96. PubMed ID: 7081142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.
    Boice JD; Day NE; Andersen A; Brinton LA; Brown R; Choi NW; Clarke EA; Coleman MP; Curtis RE; Flannery JT
    J Natl Cancer Inst; 1985 May; 74(5):955-75. PubMed ID: 3858584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
    Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
    Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma.
    Featherstone C; Delaney G; Jacob S; Barton M
    Cancer; 2005 Jan; 103(2):393-401. PubMed ID: 15593373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of multiple primary breast and thyroid carcinomas.
    Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
    Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.
    Chiu BC; Gapstur SM; Greenland P; Wang R; Dyer A
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2348-54. PubMed ID: 17164355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation dose and leukemia risk in patients treated for cancer of the cervix.
    Boice JD; Blettner M; Kleinerman RA; Stovall M; Moloney WC; Engholm G; Austin DF; Bosch A; Cookfair DL; Krementz ET; Latourette HB; Peters LJ; Schulz MD; Lundell M; Pettersson F; Storm HH; Bell CM; Coleman MP; Fraser P; Palmer M; Prior P; Choi NW; Hislop TG; Koch M; Robb D; Robson D; Spengler RF; von Fournier D; Frischkorn R; Lochmüller H; Pompe-Kirn V; Rimpela A; Kjørstad K; Pejovic MH; Sigurdsson K; Pisani P; Kucera H; Hutchison GB
    J Natl Cancer Inst; 1987 Dec; 79(6):1295-311. PubMed ID: 3480381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.